Nucleus Network

Exhibitor

Nucleus Network is the only multi-site phase I clinical trials provider with phase I facilities located in Australia and the USA. We provide high-quality, first-in-human and early-phase-patient trials for biotechnology and pharmaceutical companies across the USA, Europe and Asia. Access to patients, shortened recruitment timelines and the evolution of pharmacodynamic (PD) biomarkers are key fundamentals underpinning Nucleus Networks multi-country, multi-site approach to Phase 1 clinical trials.